SGJ-17980-46990 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-26
Registered in v-safe
2021-05-26
Dose 1 — Janssen/Johnson & Johnson
2021-05-26
Health check-in — day 0, dose 1
Feeling: Fair · Fever · Headache, Muscle or body aches

Adult check-in
2021-05-27
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2022-05-28
Survey response — 12 months, dose 1
MedDRA: Autoimmune disorder, Neuropathy peripheral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: I developed autoimmune peripheral neuropathy

MedDRA releases: 2024-11 · check-in free text available
2022-05-28
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-06-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-26	Janssen/Johnson & Johnson

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — 12 months, dose 1

2022-05-28

Symptoms: I developed autoimmune peripheral neuropathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Autoimmune disorder	·	·	✓
SD	Neuropathy peripheral	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release